Company Overview and News
A recent US court ruling green-lighting the merger between AT&T (NYSE:T) and Time Warner (NYSE:TWX) marked an historic event that some say could open the door to more merger-and-acquisition (M&A) activity ahead. Sara Araghi, CFA, vice president, research analyst, Franklin Equity Group, and Marc Kremer, CFA, research analyst, Franklin Templeton Fixed Income Group, discuss some of the possible implications.
FOX FB TMUS CMCSA TWX NFLX GOOG TWC S AMZN T GOOGL FOXA
The Net Neutrality laws, which were repealed by the Federal Communications Commission (“FCC”) on Dec 14, 2017, finally received the death knell on Jun 11. The newly constructed FCC under Trump administration with Ajit Pai at the helm rescinded the Obama-era open-Internet rules. Notably, the rules had altered the dynamics of the Internet Service Providers (ISP) industry.
CHTR FB T GOOGL CMCSA TWTR VZ NFLX GOOG
WASHINGTON: The U.S. Supreme Court on Friday imposed limits on the ability of police to obtain cellphone data pinpointing the past location of criminal suspects in a major victory for digital privacy advocates and a setback for law enforcement authorities.
S TMUSP GOOGL TMUS VZ MSFT GOOG VZA
Investing solely for income, and finding the best dividend stocks, can be tricky. High dividend yields sound attractive on the surface, but almost always come with sharply higher risks. The largest risk is that the very same dividend will be cut. Those cuts usually have a doubled impact. They reduce — or eliminate — the income stream investors were buying in the first place. And as shareholders in companies like General Electric (NYSE:GE), Frontier Communications (NASDAQ:FTR) and Mattel (NASDAQ:MAT) have learned, they often coincide with steep declines in the share price as well.
GIS PG GOOG SBRA AMZN FTRPR GM.WS.A GM.WS.B GM.WS.C GM CVA SBRAP GE F GEC UPS WYNN FDX NYTAB MAT GOOGL TSLA GNE LVS GM.WSB FTR
Ansys (NASDAQ:ANSS) moved up by nearly 4% after an upgrade from Goldman Sachs Group Inc (NYSE:GS). The Canonsburg, Pennsylvania-based engineering simulation software company was upgraded on improving productivity and profits. However, after massive amounts of growth over the last 18 months, this upgrade is too late to benefit new Ansys stock investors.
JBK GS.PRICL GSC TFG GS.PRB ANSS GS.PRA GOOG GSJ GS.PRJ PTC GS GS.PRI GLSSP GOOGL GS.PRD GS.PRC MSFT ADSK GJS GS.PRN GS.PRK
In a concerted move to exit the capital-intensive data center business and reduce debt, AT&T Inc. (T - Free Report) has inked an agreement with Brookfield Infrastructure and its institutional partners to divest the properties and related assets. The transaction worth $1.1 billion is likely to be completed by the end of the year subject to mandatory closing conditions and regulatory approvals. Under the terms of the agreement, AT&T will transfer the ownership of 18 Internet Data Centers in the United States and 13 in international locations to Brookfield.
FB GOOGL TWX VZ GOOG TWC VZA
BRUSSELS – Europe is proposing to do away with key legal protections enjoyed by Google, Facebook and other internet giants, a shift that could lead web platforms to block certain posts by users.
SAN FRANCISCO (Reuters) - YouTube said on Thursday that video uploaders with more than 100,000 followers could start paid fan clubs on the service, one of several new features aimed at helping itself and its users diversify revenue after a turbulent year.
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.
FB GOOGL GOOG
After years where it husbanded resources in favor of paying dividends, AT&T (NYSE:T) was finally able to break out of its telecom box this week and buy Time Warner, now renamed WarnerMedia.
FB AMZN T GOOGL TWX MSFT GOOG TWC
2018-06-22 - Asif
Overview Cascadian Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapeutic products for the treatment of cancer. The company's goal is to develop and commercialize novel targeted compounds that have the potential to improve the lives and outcomes of cancer patients. The company's lead clinical-stage product candidate is tucatinib, an oral, HER2-selective small molecule tyrosine kinase inhibitor. The company's pipeline also includes two preclinical-stage product candidates: CASC-578, a Chk1 kinase inhibitor, and CASC-674, an antibody program against an immuno-oncology target known as TIGIT. 2018 Merger Agreement On January 30, 2018, the company entered into an Agreement and Plan of Merger (the Merger Agreement) with Seattle Genetics, Inc., a Delaware corporation (Seattle Genetics), and Valley Acquisition Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Seattle Genetics (Merger Sub). Pursuant to the Merger ...
2018-06-22 - Asif
Business Overview The Corporation is a Delaware corporation, a bank holding company (BHC) and a financial holding company. When used in this report, “the Corporation” may refer to Bank of America Corporation individually, Bank of America Corporation and its subsidiaries, or certain of Bank of America Corporation’s subsidiaries or affiliates. The company's principal executive offices are located in Charlotte, North Carolina. Through its banking and various nonbank subsidiaries throughout the U.S. and in international markets, the company provide a diversified range of banking and nonbank financial services and products through four business segments: Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking and Global Markets, with the remaining operations recorded in All Other. The company operate its banking activities primarily under the Bank of America, National Association (Bank of America, N.A. or BANA) charter. At March 31, 2018, the Corporation had a...
2018-06-18 - Asif
Business Arrowhead develops medicines that treat intractable diseases by silencing the genes that cause them. Using a broad portfolio of RNA chemistries and efficient modes of delivery, Arrowhead therapies trigger the RNA interference mechanism to induce rapid, deep and durable knockdown of target genes. RNA interference, or RNAi, is a mechanism present in living cells that inhibits the expression of a specific gene, thereby affecting the production of a specific protein. Deemed to be one of the most important recent discoveries in life science with the potential to transform medicine, the discoverers of RNAi were awarded a Nobel Prize in 2006 for their work. Arrowhead’s RNAi-based therapeutics leverage this natural pathway of gene silencing. In fiscal 2017, Arrowhead refocused its resources on therapeutics that exclusively utilize the company’s Targeted RNAi Molecule (TRiMTM) platform technology. Therapeutics built on the TRiMTM platform have demonstrated high levels of pha...
Silicon Investor Message Boards
This table lists all message boards related to GOOG / Alphabet Inc. Class C on message board site Silicon Investor.
as of ET